Lead Product(s) : Procarbazine Hydrochloride
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Procarbazine Hydrochloride Capsule (Natulan®) Clinical Trial Protocol
Details : Natulan is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Hodgkin Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 15, 2016
Lead Product(s) : Procarbazine Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
